Versions of 42 USC 300cc-12 - Use of investigational new drugs with respect to acquired immune deficiency syndrome on LawServer 2024 42 USC 300cc-12 – Use of investigational new drugs with respect to acquired immune deficiency syndrome 2023 42 USC 300cc-12 – Use of investigational new drugs with respect to acquired immune deficiency syndrome 2022 42 USC 300cc-12 – Use of investigational new drugs with respect to acquired immune deficiency syndrome 2021 42 USC 300cc-12 – Use of investigational new drugs with respect to acquired immune deficiency syndrome 2020 42 USC 300cc-12 – Use of investigational new drugs with respect to acquired immune deficiency syndrome 2018 42 USC 300cc-12 – Use of investigational new drugs with respect to acquired immune deficiency syndrome 2017 42 USC 300cc–12 – Use of investigational new drugs with respect to acquired immune deficiency syndrome 2015 42 USC 300cc–12 – Use of investigational new drugs with respect to acquired immune deficiency syndrome 2014 42 USC 300cc-12 – Use of investigational new drugs with respect to acquired immune deficiency syndrome 2013 42 USC 300cc-12 – Use of investigational new drugs with respect to acquired immune deficiency syndrome 2012 42 USC 300cc-12 – Use of investigational new drugs with respect to acquired immune deficiency syndrome 2010 42 USC 300cc-12 – Use of investigational new drugs with respect to acquired immune deficiency syndrome